T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Richard P Junghans, PhD, MD Roger Williams Medical Center - Roger Williams Medical Center - Document - PDFSEARCH.IO

First Page	Meta Content
	T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Richard P Junghans, PhD, MD Roger Williams Medical Center Add to Reading List Document Date: 2014-01-13 09:36:10 Open Document File Size: 683,28 KB Share Result on Facebook Company AEs / / Facility MD Roger Williams Medical Center Boston University Medical Center / / MedicalCondition Adenocarcinoma Myeloablative Conditioning Adenocarcinomas / tumor / solid tumor / GD2 neuroblastoma studies / Lung/dyspnea / Liver Metastases / Trials Disease / Adenocarcinomas Disease / indication/Research Participant population Adenocarcinomas / Advanced CEA Immunoglobulin-T Cell Receptors Prostate Cancer / Bowel/colitis / / MedicalTreatment CCR / / Organization Boston University / / Position 2nd Generation Anti-CEA Designer / PSMA Designer / 2nd Generation Designer / / Product mesna / / Technology Cell Receptors / / SocialTag Molecular biology Prostate cancer Retrovirus Prostate-specific membrane antigen Immunotherapy Cancer immunotherapy Neuroblastoma Lentivirus Medicine Oncology

T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Richard P Junghans, PhD, MD Roger Williams Medical CenterAdd to Reading List